威高血净：10月29日召开董事会会议
Shandong Weigao Blood Purification ProductsShandong Weigao Blood Purification Products(SH:603014) Mei Ri Jing Ji Xin Wen·2025-10-30 18:24

Company Overview - Weigao Blood Products (SH 603014) announced the convening of its 16th meeting of the second board of directors on October 29, 2025, to review the proposal for the company's Q3 2025 report [1] Financial Performance - For the first half of 2025, Weigao Blood Products reported a revenue composition where consumables accounted for 77.55%, equipment accounted for 18.25%, other businesses accounted for 2.35%, and other categories accounted for 1.85% [1]